OMB
Live / Registered — Registered (as of 18 Jul 2023)
What this means for you
Registered since 18 Jul 2023. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 90380281
- Registration number
- 7115850
- Mark type
- Design + words
- Filed
- 14 Dec 2020
- Published for opposition
- 05 Oct 2021
- Registered
- 18 Jul 2023
- Attorney of record
- Maury M. Tepper, III
Goods and services
- Class 005 — Pharmaceuticals: pharmaceutical preparations acting on the central nervous system
Owner
- Novartis AG, Basel, CH
- Novartis AG, Basel, CH
- Novartis AG, Basel, CH
Prosecution history
- 18 Jul 2023 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 18 Jul 2023 — REGISTERED-PRINCIPAL REGISTER
- 16 Jun 2023 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 15 Jun 2023 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 30 May 2023 — STATEMENT OF USE PROCESSING COMPLETE
- 05 May 2023 — USE AMENDMENT FILED
- 30 May 2023 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 05 May 2023 — TEAS STATEMENT OF USE RECEIVED
- 29 Nov 2022 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 27 Nov 2022 — SOU EXTENSION 2 GRANTED
- 27 Nov 2022 — SOU EXTENSION 2 FILED
- 27 Nov 2022 — SOU TEAS EXTENSION RECEIVED
- 24 May 2022 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 22 May 2022 — SOU EXTENSION 1 GRANTED
- 22 May 2022 — SOU EXTENSION 1 FILED